Immediate Impact
20 standout
Citing Papers
Nanoparticles in cancer theragnostic and drug delivery: A comprehensive review
2024 Standout
Cancer stem cells: advances in knowledge and implications for cancer therapy
2024 Standout
Works of Bing Peng being referenced
Preclinical pharmacodynamic evaluation of a new Src/FOSL 1 inhibitor, LY ‐1816, in pancreatic ductal adenocarcinoma
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Bing Peng | 555 | 398 | 502 | 63 | 750 | |
| H. Becker | 524 | 315 | 523 | 35 | 862 | |
| Yunqiang Cai | 483 | 348 | 473 | 72 | 706 | |
| Hee Kyung Kim | 263 | 359 | 428 | 63 | 768 | |
| Wilson Luiz da Costa | 389 | 351 | 280 | 68 | 746 | |
| Kazunari Nakahara | 261 | 380 | 479 | 105 | 793 | |
| Maria Sheridan | 412 | 349 | 578 | 40 | 872 | |
| Fabio Uggeri | 260 | 288 | 476 | 65 | 802 | |
| Davide Bova | 207 | 303 | 331 | 58 | 878 | |
| Masashi Hattori | 315 | 273 | 355 | 47 | 689 | |
| Sivakumar Gananadha | 258 | 284 | 454 | 51 | 650 |
All Works
Login with ORCID to disown or claim papers
Loading papers...